Literature DB >> 27821544

Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia.

M Biosse Duplan1,2,3, B R Coyac4, C Bardet4, C Zadikian1,2, A Rothenbuhler3,5, P Kamenicky3,5, K Briot3,6, A Linglart3,5, C Chaussain1,3,4.   

Abstract

X-linked hypophosphatemia (XLH) is a rare genetic skeletal disease where increased phosphate wasting in the kidney leads to hypophosphatemia and prevents normal mineralization of bone and dentin. Here, we examined the periodontal status of 34 adults with XLH and separated them according to the treatment they received for hypophosphatemia. We observed that periodontitis frequency and severity were increased in adults with XLH and that the severity varied according to the hypophosphatemia treatment. Patients who benefited from an early and continuous vitamin D and phosphate supplementation during their childhood presented less periodontal attachment loss than patients with late or incomplete supplementation. Continued hypophosphatemia treatment during adulthood further improved the periodontal health. Extracted teeth from patients with late or incomplete supplementation showed a strong acellular cementum hypoplasia when compared with age-matched healthy controls. These results show that XLH disturbs not only bone and dentin formation but also cementum and that the constitutional defect of the attachment apparatus is associated with attachment loss.

Entities:  

Keywords:  alveolar bone loss; dental cementum; hypophosphatemic rickets; osteomalacia; periodontal attachment loss; periodontal disease

Mesh:

Substances:

Year:  2016        PMID: 27821544     DOI: 10.1177/0022034516677528

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  31 in total

1.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

Review 2.  The role of biomineralization in disorders of skeletal development and tooth formation.

Authors:  Christopher S Kovacs; Catherine Chaussain; Philip Osdoby; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

3.  Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia.

Authors:  H Zhang; M B Chavez; T N Kolli; M H Tan; H Fong; E Y Chu; Y Li; X Ren; K Watanabe; D G Kim; B L Foster
Journal:  J Dent Res       Date:  2020-01-24       Impact factor: 6.116

Review 4.  Congenital Conditions of Hypophosphatemia Expressed in Adults.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-05-14       Impact factor: 4.333

Review 5.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

6.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

7.  Insights into dental mineralization from three heritable mineralization disorders.

Authors:  Michael B Chavez; Kaitrin Kramer; Emily Y Chu; Vivek Thumbigere-Math; Brian L Foster
Journal:  J Struct Biol       Date:  2020-08-03       Impact factor: 2.867

8.  Hypercementosis Associated with ENPP1 Mutations and GACI.

Authors:  V Thumbigere-Math; A Alqadi; N I Chalmers; M B Chavez; E Y Chu; M T Collins; C R Ferreira; K FitzGerald; R I Gafni; W A Gahl; K S Hsu; M S Ramnitz; M J Somerman; S G Ziegler; B L Foster
Journal:  J Dent Res       Date:  2017-12-15       Impact factor: 6.116

9.  Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets.

Authors:  Giampiero I Baroncelli; Elisa Zampollo; Mario Manca; Benedetta Toschi; Silvano Bertelloni; Angela Michelucci; Alessandro Isola; Alessandra Bulleri; Diego Peroni; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2020-08-08       Impact factor: 2.626

Review 10.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.